Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What physicians should know about the management of chronic hepatitis B in children: East side story.

Literature DB >> 24707141

What physicians should know about the management of chronic hepatitis B in children: East side story.

Abstract

Understanding the natural course of chronic hepatitis B virus (HBV) infection is very important for the management and treatment of chronic hepatitis B in children. Based on treatment guidelines, the management of HBV carriers and treatment of active hepatitis have been advancing and resulted in increased survival, as well as decreased risks of complications such as liver cirrhosis and hepatocellular carcinoma. Development of a continuing medical education (CME) program for primary physicians becomes an important responsibility of pediatric hepatologists. CME could prevent misdiagnosis and unnecessary treatment that could lead to liver complications or antiviral resistance. In addition, education of patients and their parents is necessary to achieve better therapeutic outcomes.

Entities: Disease Species

Keywords: Diagnosis; Hepatitis B virus; Lamivudine; Natural course; Resistance; Treatment

Mesh：

Substances：

Year: 2014 PMID： 24707141 PMCID： PMC3974525 DOI： 10.3748/wjg.v20.i13.3582

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

45 in total

Review 1. Hepatitis B e antigen-negative chronic hepatitis B.

Authors: S J Hadziyannis; D Vassilopoulos
Journal: Hepatology Date: 2001-10 Impact factor: 17.425

2. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.

Authors: George Zacharakis; John Koskinas; Stamatia Kotsiou; Evaggelia Pouliou; Menelaos Papoutselis; Fevronia Tzara; Nikolaos Vafeiadis; Eustratios Maltezos; Athanasios Archimandritis; Kostantinos Papoutselis
Journal: J Pediatr Gastroenterol Nutr Date: 2007-01 Impact factor: 2.839

3. Pathology of chronic hepatitis B virus infection in children: with special reference to the intrahepatic expression of hepatitis B virus antigens.

Authors: H C Hsu; Y H Lin; M H Chang; I J Su; D S Chen
Journal: Hepatology Date: 1988 Mar-Apr Impact factor: 17.425

4. Natural history of hepatitis B virus infection in children.

Authors: M H Chang
Journal: J Gastroenterol Hepatol Date: 2000-05 Impact factor: 4.029

5. Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

Authors: M F Yuen; E Sablon; C K Hui; H J Yuan; H Decraemer; C L Lai
Journal: Hepatology Date: 2001-10 Impact factor: 17.425

6. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

Authors: B J McMahon; W L Alward; D B Hall; W L Heyward; T R Bender; D P Francis; J E Maynard
Journal: J Infect Dis Date: 1985-04 Impact factor: 5.226

7. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.

Authors: M I Allen; M Deslauriers; C W Andrews; G A Tipples; K A Walters; D L Tyrrell; N Brown; L D Condreay
Journal: Hepatology Date: 1998-06 Impact factor: 17.425

8. Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger.

Authors: Gregory E Kobak; Todd MacKenzie; Ronald J Sokol; Michael R Narkewicz
Journal: J Pediatr Date: 2004-09 Impact factor: 4.406

9. Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.

Authors: F Bortolotti; R Calzia; P Cadrobbi; R Giacchini; B Ciravegna; M Armigliato; R Piscopo; G Realdi
Journal: J Pediatr Date: 1986-02 Impact factor: 4.406

10. Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine.

Authors: Hidehiro Kamezaki; Tatsuo Kanda; Makoto Arai; Shuang Wu; Shingo Nakamoto; Tetsuhiro Chiba; Hitoshi Maruyama; Keiichi Fujiwara; Fumihiko Kanai; Fumio Imazeki; Fumio Nomura; Osamu Yokosuka
Journal: Int J Med Sci Date: 2013-03-15 Impact factor: 3.738

8 in total

1. A disappearing vertical infection: will hepatitis B be a forgotten disease in children?

Authors: Byung-Ho Choe
Journal: Korean J Intern Med Date: 2014-04-29 Impact factor: 2.884

Review 2. Lamivudine resistance in children with chronic hepatitis B.

Authors: Erhun Kasırga
Journal: World J Hepatol Date: 2015-04-28

3. Clinical Predictors of Functional Cure in Children 1-6 Years-old with Chronic Hepatitis B.

Authors: Jing Pan; Haiyan Wang; Tiantian Yao; Xuejiao Liao; Hao Cheng; Suthat Liangpunsakul; Yan Wang; Min Zhang; Zheng Zhang
Journal: J Clin Transl Hepatol Date: 2022-01-04

4. What Are the Main Differences in the Treatment of Chronic Hepatitis B between Korean Children and Adults?

Authors: Byung Ho Choe
Journal: J Korean Med Sci Date: 2018-02-19 Impact factor: 2.153

5. Diagnosis experiences from 50 hepatitis B patients in Chongqing, China: a qualitative study.

Authors: Xiangxi Zhou; Fan Zhang; Yongping Ao; Chunli Lu; Tingting Li; Xianglong Xu; Huan Zeng
Journal: BMC Public Health Date: 2021-12-01 Impact factor: 3.295

Review 6. Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries.

Authors: Ben Kang; Dae Yong Yi; Byung-Ho Choe
Journal: Front Pediatr Date: 2022-02-04 Impact factor: 3.418

Review 7. The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics.

Authors: Anna Kramvis
Journal: Rev Med Virol Date: 2016-05-03 Impact factor: 6.989

8. Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B.

Authors: Jae Young Choe; Jae Sung Ko; Byung Ho Choe; Jung Eun Kim; Ben Kang; Kyung Jae Lee; Hye Ran Yang
Journal: J Korean Med Sci Date: 2018-01-08 Impact factor: 2.153

8 in total